COMBINATION THERAPIES WITH DISULFIRAM
Disclosed herein are compositions and methods for increasing lifespan, for preventing or treating a disease including an aging-related disorder, for reducing a symptom of aging, and/or boosting an immune system in a mammal. Also disclosed herein are compositions and methods for improving effectiveness of a vaccine in a mammal. The compositions comprise, at least, a therapeutically effective amount of disulfiram and one or more additional ingredients.
1 .- 20 . (canceled)
21 . A method for inhibiting and/or reducing pyroptotic cell death in a cell, the method comprising contacting the cell with an active agent that is disulfiram and a potentiating ingredient that is cinnamaldehyde, thereby inhibiting and/or reducing pyroptotic cell death.
22 . The method of claim 21 , wherein disulfiram and cinnamaldehyde are included in one composition and the composition comprises disulfiram and cinnamaldehyde.
23 . The method of claim 21 , wherein the method comprises contacting the cell with a first composition comprises disulfiram and contacting the cell with a second composition comprising cinnamaldehyde.
24 . The method of claim 21 , wherein inhibiting and/or reducing pyroptotic cell death in the cell increases the lifespan of the cell.
25 . The method of claim 21 , wherein the amount of disulfiram is from about 5 mg to about 500 mg and the amount of cinnamaldehyde is from about 0.01% to about 45% by weight of disulfiram.
26 . The method of claim 21 , wherein the cinnamaldehyde further potentiates disulfiram's ability to treat acute lung injury (ALI), acute respiratory distress syndrome (ARDS), idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, dry eye, actinic keratosis, alopecia, and/or skin cancer.
27 . The method of claim 21 , wherein the cinnamaldehyde further potentiates disulfiram's ability to inhibit and/or reduce a pathological inflammatory response, alter a T-cell's age, and/or alter mitochondrial function in the cell.
28 . A method for boosting activity of an immune cell, the method comprising contacting the immune cell with an active agent that is disulfiram and a potentiating ingredient that is cinnamaldehyde, thereby boosting activity of the immune cell.
29 . The method of claim 28 , wherein disulfiram and cinnamaldehyde are included in one composition.
30 . The method of claim 28 , wherein the method comprises contacting the immune cell with a first composition comprising disulfiram and contacting the cell with an at least second composition comprising cinnamaldehyde.
31 . The method of claim 28 , wherein boosting activity of the immune cell increases an effective immune response against an infectious agent and/or an atypical cell.
32 . The method of claim 28 , wherein boosting activity of the immune cell improves the immune cell's response against a component contained in a vaccine, wherein the component contained in the vaccine is an antigen obtained from, related to, homologous to, or expressed by an infectious agent.
33 . The method of claim 28 , wherein boosting activity of the immune cell comprises inhibiting a pathological immune response.
34 . The method of claim 33 , wherein boosting activity of the immune cell minimizes overactive immune cell activity.
35 . The method of claim 28 , wherein the amount of disulfiram is from about 5 mg to about 500 mg and the amount of cinnamaldehyde is from about 0.01% to about 45% of the weight of the disulfiram.
36 . A composition comprising an active agent that is disulfiram and a potentiating ingredient that is cinnamaldehyde, wherein the amount of disulfiram is from about 5 mg to about 500 mg and the amount of cinnamaldehyde is from about 0.01% to about 45% of the of the disulfiram.